Study Evaluating the Effects of Red Grape Juice Consumption on Metabolism in Men With Coronary Artery Disease
GRAPEOMICS
Effects of Red Grape Juice on the Plasma Metabolome in Chronic Coronary Artery Disease.
1 other identifier
interventional
50
1 country
1
Brief Summary
Previous studies suggest that both RW and red grape juice (RGJ) have beneficial properties upon risk factors and cardiovascular events. However, the effects of grape polyphenols on metabolomics in men are still poorly understood. Recent advances in mass spectroscopy allowed substantial advances in the analysis of molecular signatures of several diseases. Therefore, the objective of this study is to evaluate the impact of RGJ on plasma metabolomics in patients with chronic coronary disease (CAD). This is a crossover, prospective, randomized and controlled study, with two 3-week interventions: 1. daily consumption of RGJ (400 mL) and 2. total abstention from foods rich in polyphenols. Plasma metabolomics will be performed by gas chromatography (GC)/mass spectroscopy (MS) by (Prof. Labate, Department of Plant Genetics, ESALQ). The sample will consist of 50 patients with chronic CAD. aged between 46 and 69 years. The inclusion and exclusion criteria were defined to achieve homogeneity of the group and avoid interference. The central hypothesis of this study is that RGJ will exert effects upon pathways involved in lipids, carbohidrates and energy production, contributing to the understanding of the mechanisms of action of polyphenols on cardiovascular health, without the risks associated with alcohol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2026
CompletedFirst Submitted
Initial submission to the registry
August 17, 2026
CompletedFirst Posted
Study publicly available on registry
August 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 10, 2028
August 28, 2026
August 1, 2026
1.9 years
August 17, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma Metabolomics Changes
Change in plasma metabolomic profile after red grape juice consumption compared with the abstinence period.
From enrollment to the end of treatment at 10 weeks
Study Arms (2)
Red Juice/ Abstention
EXPERIMENTALGroup 1(Red Juice/ Abstention) will first consume 400 mL of red grape juice per day, five days per week, for three weeks, followed by a period of abstinence from polyphenol-rich foods.
Abstention/ Red Juice
EXPERIMENTALGroup 2 (Abstention/ Red Juice) will follow the same interventions in the opposite order, beginning with the abstinence period and then consuming red grape juice.
Interventions
Participants will undergo two 3-week intervention periods in random order: daily consumption of 400 mL of red grape juice and a control period involving complete abstinence from polyphenol-rich foods.
Eligibility Criteria
You may qualify if:
- Age between 46 and 69 years.
- Established chronic coronary artery disease, defined by at least one of the following:
- Acute myocardial infarction occurring more than 30 days before enrollment;
- Angiographic evidence of ≥50% stenosis in one or more epicardial coronary arteries;
- Previous percutaneous coronary intervention (PCI);
- Previous coronary artery bypass grafting (CABG).
- BMI \<30 kg/m².
- Absence of:
- Angina symptoms;
- Dyspnea.
You may not qualify if:
- Use of antibiotics within 8 weeks before study enrollment.
- Heart failure, NYHA functional class ≥ II.
- Renal insufficiency, defined as creatinine clearance \<30 mL/min, calculated using the Cockcroft-Gault equation.
- Hepatic insufficiency, defined by:
- Thrombocytopenia;
- Reduced serum albumin;
- Prolonged prothrombin time.
- Cancer.
- Inflammatory bowel disease.
- Obstructive biliary disease.
- History of digestive tract surgery, including:
- Cholecystectomy;
- Gastrectomy;
- Colectomy.
- Diabetes mellitus.
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Incor - Instituto do Coração HCFMUSP
São Paulo, São Paulo, 05403-000, Brazil
Related Publications (1)
Ghaedi E , Moradi S , Aslani Z , Kord-Varkaneh H , Miraghajani M , Mohammadi H . Effects of grape products on blood lipids: a systematic review and dose-response meta-analysis of randomized controlled trials. Food Funct. 2019 Oct 16;10(10):6399-6416. doi: 10.1039/c9fo01248f.
PMID: 31517353BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Antonio Carlos Palandri Chagas
Incor - Instituto do Corção HCFMUSP
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Doctor
Study Record Dates
First Submitted
August 17, 2026
First Posted
August 20, 2026
Study Start
July 10, 2026
Primary Completion (Estimated)
June 10, 2028
Study Completion (Estimated)
August 10, 2028
Last Updated
August 28, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share